Skip to main content
Top
Published in: Endocrine 3/2022

19-08-2022 | COVID-19 Vaccination | Letter to the Editor

Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination

Authors: Rujittika Mungmunpuntipantip, Viroj Wiwanitkit

Published in: Endocrine | Issue 3/2022

Login to get access

Excerpt

Dear Editor, we would like to share ideas on “Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination [1]” Aydoan et al. discovered that vaccine-induced autoimmune diabetes may be the cause of acute impairment of glucose regulation in a patient after BNT162b2 treatment [1]. Despite the likelihood of side effects from the COVID-19 immunization, clinical medicine places a lot of focus on the COVID-19 vaccine’s clinical impact on other systems. The current report may or may not constitute an adverse reaction to a vaccination. The recipient’s immune, endocrinological, or physical health pre-vaccination records are not readily available. It is difficult to make a clear, firm decision regarding the clinical relationship between vaccination and type 1 diabetes. A person who has received vaccines could possibly be comorbid. Additionally, the vaccine recipient could get a different illness. Clinical dengue infection can also occur after receiving the COVID-19 vaccination [2]. For instance, dengue illness can cause and co-occur with type 1 diabetes [3]. …
Metadata
Title
Type 1 diabetes mellitus following SARS-CoV-2 mRNA vaccination
Authors
Rujittika Mungmunpuntipantip
Viroj Wiwanitkit
Publication date
19-08-2022
Publisher
Springer US
Published in
Endocrine / Issue 3/2022
Print ISSN: 1355-008X
Electronic ISSN: 1559-0100
DOI
https://doi.org/10.1007/s12020-022-03169-7

Other articles of this Issue 3/2022

Endocrine 3/2022 Go to the issue